Precision VIR Announces Non-surgical Option for Patients with Varicose Veins

Vein expert doctors at Precision VIR in Dallas, TX announce Varithena as a non-surgical option for varicose vein patients. Sadly, vein disease does not cure itself and can get worse if untreated. Precision VIR can reduce varicose vein symptoms and improve leg appearance.

Dallas, United States - April 17, 2018 /PressCable/ —

Precision VIR Announces Availability of Varithena® as a Non-Surgical Option for Patients with Symptoms Related to or Caused by Varicose Veins

The Cutting-Edge Procedure can Reduce a Variety of Symptoms and Improve Vein Appearance

Dallas, TX (April 16, 2018) – The doctors at Precision Vascular & Interventional recently announced they incorporated Varithena® (polidocanol injectable foam) into the growing list of superior vein treatment options for their patients. Varithena is a non-surgical prescription medicine many believe can be a game-changer when it comes to treating varicose veins, specifically in combating the symptoms of heaviness, achiness, swelling, throbbing and itching.

“Precision VIR is delighted to provide patients with this non-surgical option,” Dr. Danny Chan said on behalf of himself, Dr. Jaryd Stein, and their associate vein specialists. “We have been specially trained in using Varithena. Treatment is minimally-invasive—which means no incision is required.”

Dr. Chan added, “The Varithena procedure usually takes less than one hour, and patients may resume light activities as quickly as the same day of treatment.”

More About Varicose Veins and Varithena

Varicose veins are enlarged bulging veins usually found above the surface of the skin on the legs and are a telltale sign of vein disease, where vein walls and valves have become weakened and eventually interrupt normal blood flow. These veins can range from the most common spider and varicose veins to skin breakdown and venous ulcers. More than 20 million Americans suffer from vein disease or venous disorders.

Sadly, vein disease does not cure itself and can get worse if left untreated. Luckily, there are a variety of treatment options available for patients with venous conditions, including Varithena, Sclerotherapy, ClosureFast, and Microphlebectomy.

Varithena (polidocanol injectable foam) is the latest option. It is administered through a catheter or by direct injection into the malfunctioning vein. The foam fills the desired section of the vein, and the diseased vein collapses. Blood flow then shifts to healthier veins nearby. This procedure does not require incisions. While the doctor usually numbs the injection site, no additional anesthesia is required.

Varithena treats a wide range of varicose veins in the GSV system, including:

• Tortuous (twisted) veins

• Veins above and below the knee

• Veins with small, medium, and large diameters

• Veins previously treated with other methods

Varithena® is a registered trademark of Provensis Ltd, a BTG International group company.

Precision VIR – Committed to Helping Patients Lead Normal Lives

Precision VIR has long been at the forefront of performing leading-edge procedures to treat vein disease such as varicose veins, spider veins, deep vein thrombosis (DVT), chronic venous insufficiency (CVI), and peripheral arterial disease/peripheral vascular disease (PAD/PVD)—all while providing compassionate patient care.

With multiple locations in the Dallas-Fort Worth area, Precision VIR was established in 2012 as the first independent Vascular and Interventional Radiology practice in North Texas. They focus only on minimally-invasive procedures and surgeries that are the safest and most efficient options for patients. There are no large incisions, which allows for a reduction in risk, less pain, and shorter recovery time.

All physicians at Precision VIR are Board Certified Diagnostic Radiologists with additional Fellowship training in Vascular and Interventional Radiology. Precision VIR serves Dallas, Fort Worth, Carrollton, Richardson, Garland, Mesquite, Highland Park, University Park, Park Cities, Plano, Frisco, Allen, McKinney, Flower Mound, Lewisville, Denton, Arlington, Irving, Grand Prairie and all of North Texas. Precision VIR doctors are area leaders in vascular disease diagnosis and treatment for conditions such as varicose veins, spider veins, deep vein thrombosis (DVT), chronic venous insufficiency (CVI), peripheral arterial disease/peripheral vascular disease (PAD/PVD), IVC filters, women’s pelvic congestion syndrome, male varicoceles and female uterine fibroids.

For more information on Varithena, visit the Precision VIR FAQ page or to see if this procedure is the right treatment for your varicose veins, schedule a consultation by calling (214) 382-3200.

– end –

###

Contact Info:
Name: Shauna Robinson or Madison Horan
Email: info@precisionvir.com
Organization: Precision VIR
Address: 12400 Coit Road, Suite 505, Dallas, TX 75251, United States
Phone: +1-214-382-3200

For more information, please visit https://www.precisionvir.com/vein-care-dallas/

Source: PressCable

Release ID: 331770

Latest News

Analysis: China plays hardball with ex-diplomat's seizure

Dec 12, 2018

BEIJING — China is playing hardball with the detention of a former Canadian diplomat days after Canada arrested a leading Chinese executive. In many ways it looks like a classic Chinese response to perceived slights: Deny any wrongdoing, seize the moral high ground and exert maximum pressure to extract concessions. But Beijing's detention of Michael Kovrig also reflects an increasingly bold approach to international disputes under President Xi Jinping, who has overseen a vast expansion of China's diplomatic, military and economic power. China has often retaliated against foreign governments and corporations in diplomatic disputes, but rarely by holding a foreign...

China and US discuss plans for trade talks

Dec 12, 2018

BEIJING — China's economy czar and U.S. trade envoys discussed plans for talks on a tariff battle, the government said Tuesday, indicating that negotiations are going ahead despite tension over the arrest of a Chinese tech executive. Vice Premier Liu He talked by phone with Treasury Secretary Steven Mnuchin and U.S. Trade Representative Robert Lighthizer about "the promotion of the next economic and trade consultations," said a two-sentence Commerce Ministry statement. It gave no other details. Lighthizer's office confirmed the phone call with Liu but provided no additional information. The announcement indicated that talks are on track despite China's weekend...

Asian shares mixed on concerns over trade, economic outlook

Dec 12, 2018

SINGAPORE — Asian markets were mixed Tuesday in narrow trading on doubts that U.S. and China can manage to resolve their festering trade dispute. KEEPING SCORE: Japan's benchmark Nikkei 225 lost 0.4 percent to 21,127.00 and South Korea's Kospi added less than 0.1 percent to 2,055.07. Hong Kong's Hang Seng edged 0.1 percent higher to 25,768.25. The Shanghai Composite rose 0.3 percent to 2,586.47. Australia's S&P/ASX 200 added 0.2 percent to 5,562.50. Shares rose in Taiwan but fell in Singapore and Indonesia. WALL STREET: Buying of technology companies spurred gains for U.S. indexes after steep losses in early trading. China...

Gene-editing Chinese scientist kept much of his work secret

Dec 12, 2018

SHENZHEN, China — The Chinese scientist who says he helped make the world's first gene-edited babies veered off a traditional career path, keeping much of his research secret in pursuit of a larger goal — making history. He Jiankui's outsized aspirations began to take shape in 2016, the year after another team of Chinese researchers sparked global debate with the revelation that they had altered the DNA of human embryos in the lab. He soon set his mind on pushing the boundaries of medical ethics even further. The China-born, U.S.-trained scientist once confided to his former Stanford University adviser his...

World markets rise despite Trump's renewed tariff threat

Dec 12, 2018

SINGAPORE — World markets were mostly higher on Tuesday despite U.S. President Donald Trump saying it's "highly unlikely" he'll hold off on raising tariffs ahead of a closely-watched meeting with his Chinese counterpart. KEEPING SCORE: Germany's DAX index gained 0.3 percent to 11,381.78 and France's CAC 40 added 0.2 percent to 5,006.05. Britain's FTSE 100 index was flat at 7,037.15. Wall Street was set for a moderate start. Futures for the broad S&P 500 index rose 0.1 percent to 2,671.20. Dow futures also gained 0.1 percent to 24,621.00. ASIA'S DAY: Japan's benchmark Nikkei 225 added 0.6 percent to 21,952.40 and...

Sign up now!